nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—Hyperuricaemia—Chlorambucil—testicular cancer	0.021	0.0258	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Chlorambucil—testicular cancer	0.0198	0.0244	CcSEcCtD
Hydroflumethiazide—CA14—seminal vesicle—testicular cancer	0.0196	0.105	CbGeAlD
Hydroflumethiazide—Vasculitis—Ifosfamide—testicular cancer	0.0132	0.0162	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Dactinomycin—testicular cancer	0.0132	0.0162	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Cisplatin—testicular cancer	0.012	0.0147	CcSEcCtD
Hydroflumethiazide—KCNMA1—gonad—testicular cancer	0.0115	0.0615	CbGeAlD
Hydroflumethiazide—Blood uric acid increased—Cisplatin—testicular cancer	0.0113	0.0139	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Etoposide—testicular cancer	0.011	0.0135	CcSEcCtD
Hydroflumethiazide—ATP1A1—embryo—testicular cancer	0.0109	0.0582	CbGeAlD
Hydroflumethiazide—CA9—testis—testicular cancer	0.0108	0.0575	CbGeAlD
Hydroflumethiazide—Jaundice—Chlorambucil—testicular cancer	0.0106	0.0131	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Etoposide—testicular cancer	0.0104	0.0127	CcSEcCtD
Hydroflumethiazide—ATP1A1—seminal vesicle—testicular cancer	0.0102	0.0547	CbGeAlD
Hydroflumethiazide—CA5B—gonad—testicular cancer	0.00991	0.0529	CbGeAlD
Hydroflumethiazide—CA4—seminal vesicle—testicular cancer	0.00946	0.0505	CbGeAlD
Hydroflumethiazide—Agranulocytosis—Vinblastine—testicular cancer	0.00931	0.0115	CcSEcCtD
Hydroflumethiazide—SLC12A1—testis—testicular cancer	0.00916	0.0489	CbGeAlD
Hydroflumethiazide—CA2—embryo—testicular cancer	0.00835	0.0446	CbGeAlD
Hydroflumethiazide—KCNMA1—testis—testicular cancer	0.0083	0.0443	CbGeAlD
Hydroflumethiazide—Pancreatitis—Ifosfamide—testicular cancer	0.00792	0.00975	CcSEcCtD
Hydroflumethiazide—CA2—seminal vesicle—testicular cancer	0.00785	0.0419	CbGeAlD
Hydroflumethiazide—Agitation—Chlorambucil—testicular cancer	0.00782	0.00962	CcSEcCtD
Hydroflumethiazide—Leukopenia—Chlorambucil—testicular cancer	0.00762	0.00937	CcSEcCtD
Hydroflumethiazide—ATP1A1—gonad—testicular cancer	0.0074	0.0395	CbGeAlD
Hydroflumethiazide—Orthostatic hypotension—Cisplatin—testicular cancer	0.00736	0.00906	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Dactinomycin—testicular cancer	0.00734	0.00903	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Ifosfamide—testicular cancer	0.00729	0.00897	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Cisplatin—testicular cancer	0.00726	0.00893	CcSEcCtD
Hydroflumethiazide—CA5B—testis—testicular cancer	0.00714	0.0381	CbGeAlD
Hydroflumethiazide—Glycosuria—Epirubicin—testicular cancer	0.00704	0.00866	CcSEcCtD
Hydroflumethiazide—Vertigo—Vinblastine—testicular cancer	0.00701	0.00862	CcSEcCtD
Hydroflumethiazide—Leukopenia—Vinblastine—testicular cancer	0.00698	0.00859	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Cisplatin—testicular cancer	0.00683	0.0084	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Chlorambucil—testicular cancer	0.0068	0.00837	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Ifosfamide—testicular cancer	0.00672	0.00827	CcSEcCtD
Hydroflumethiazide—Cramp muscle—Etoposide—testicular cancer	0.00665	0.00818	CcSEcCtD
Hydroflumethiazide—Anorexia—Chlorambucil—testicular cancer	0.00662	0.00815	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Methotrexate—testicular cancer	0.00657	0.00808	CcSEcCtD
Hydroflumethiazide—Glycosuria—Doxorubicin—testicular cancer	0.00651	0.00801	CcSEcCtD
Hydroflumethiazide—Jaundice cholestatic—Epirubicin—testicular cancer	0.00649	0.00798	CcSEcCtD
Hydroflumethiazide—Vasculitis—Methotrexate—testicular cancer	0.00624	0.00768	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Vinblastine—testicular cancer	0.00623	0.00767	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Methotrexate—testicular cancer	0.0062	0.00763	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Epirubicin—testicular cancer	0.00615	0.00756	CcSEcCtD
Hydroflumethiazide—Anorexia—Vinblastine—testicular cancer	0.00607	0.00746	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Chlorambucil—testicular cancer	0.00604	0.00743	CcSEcCtD
Hydroflumethiazide—KCNMA1—lymph node—testicular cancer	0.00602	0.0321	CbGeAlD
Hydroflumethiazide—ATP1A1—female gonad—testicular cancer	0.00601	0.0321	CbGeAlD
Hydroflumethiazide—Jaundice cholestatic—Doxorubicin—testicular cancer	0.006	0.00739	CcSEcCtD
Hydroflumethiazide—Leukopenia—Bleomycin—testicular cancer	0.0059	0.00725	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Epirubicin—testicular cancer	0.00581	0.00714	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Methotrexate—testicular cancer	0.00572	0.00704	CcSEcCtD
Hydroflumethiazide—Hyperuricaemia—Doxorubicin—testicular cancer	0.00569	0.007	CcSEcCtD
Hydroflumethiazide—CA4—female gonad—testicular cancer	0.00556	0.0297	CbGeAlD
Hydroflumethiazide—Jaundice—Etoposide—testicular cancer	0.00555	0.00682	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vinblastine—testicular cancer	0.00553	0.00681	CcSEcCtD
Hydroflumethiazide—Urticaria—Chlorambucil—testicular cancer	0.00552	0.00679	CcSEcCtD
Hydroflumethiazide—Leukopenia—Dactinomycin—testicular cancer	0.0055	0.00677	CcSEcCtD
Hydroflumethiazide—Constipation—Vinblastine—testicular cancer	0.00544	0.0067	CcSEcCtD
Hydroflumethiazide—Blood uric acid increased—Doxorubicin—testicular cancer	0.00537	0.00661	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Epirubicin—testicular cancer	0.00535	0.00659	CcSEcCtD
Hydroflumethiazide—ATP1A1—testis—testicular cancer	0.00533	0.0285	CbGeAlD
Hydroflumethiazide—Agranulocytosis—Etoposide—testicular cancer	0.00531	0.00653	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Bleomycin—testicular cancer	0.00526	0.00648	CcSEcCtD
Hydroflumethiazide—CA5B—lymph node—testicular cancer	0.00518	0.0276	CbGeAlD
Hydroflumethiazide—Agitation—Ifosfamide—testicular cancer	0.00517	0.00637	CcSEcCtD
Hydroflumethiazide—Anorexia—Bleomycin—testicular cancer	0.00512	0.0063	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Chlorambucil—testicular cancer	0.00512	0.0063	CcSEcCtD
Hydroflumethiazide—Vertigo—Ifosfamide—testicular cancer	0.00506	0.00622	CcSEcCtD
Hydroflumethiazide—Leukopenia—Ifosfamide—testicular cancer	0.00504	0.0062	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Methotrexate—testicular cancer	0.00504	0.0062	CcSEcCtD
Hydroflumethiazide—Asthenia—Chlorambucil—testicular cancer	0.00498	0.00613	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—testicular cancer	0.00495	0.00609	CcSEcCtD
Hydroflumethiazide—CA4—testis—testicular cancer	0.00493	0.0263	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Dactinomycin—testicular cancer	0.00491	0.00604	CcSEcCtD
Hydroflumethiazide—Anorexia—Dactinomycin—testicular cancer	0.00478	0.00588	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Chlorambucil—testicular cancer	0.00475	0.00585	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—testicular cancer	0.00471	0.0058	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinblastine—testicular cancer	0.00469	0.00577	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Bleomycin—testicular cancer	0.00467	0.00575	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Cisplatin—testicular cancer	0.00467	0.00574	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—testicular cancer	0.00463	0.00569	CcSEcCtD
Hydroflumethiazide—CA2—female gonad—testicular cancer	0.00461	0.0246	CbGeAlD
Hydroflumethiazide—CA1—lymph node—testicular cancer	0.00457	0.0244	CbGeAlD
Hydroflumethiazide—Asthenia—Vinblastine—testicular cancer	0.00457	0.00562	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Ifosfamide—testicular cancer	0.0045	0.00553	CcSEcCtD
Hydroflumethiazide—Vomiting—Chlorambucil—testicular cancer	0.00442	0.00543	CcSEcCtD
Hydroflumethiazide—Anorexia—Ifosfamide—testicular cancer	0.00438	0.00539	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—testicular cancer	0.00436	0.00537	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Dactinomycin—testicular cancer	0.00436	0.00536	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinblastine—testicular cancer	0.00435	0.00536	CcSEcCtD
Hydroflumethiazide—Leukopenia—Cisplatin—testicular cancer	0.00434	0.00535	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—testicular cancer	0.00429	0.00528	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—testicular cancer	0.00428	0.00527	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Etoposide—testicular cancer	0.00427	0.00526	CcSEcCtD
Hydroflumethiazide—Urticaria—Bleomycin—testicular cancer	0.00427	0.00525	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinblastine—testicular cancer	0.00421	0.00518	CcSEcCtD
Hydroflumethiazide—Nausea—Chlorambucil—testicular cancer	0.00413	0.00508	CcSEcCtD
Hydroflumethiazide—CA2—testis—testicular cancer	0.00409	0.0218	CbGeAlD
Hydroflumethiazide—Vomiting—Vinblastine—testicular cancer	0.00405	0.00498	CcSEcCtD
Hydroflumethiazide—Vertigo—Etoposide—testicular cancer	0.00399	0.00491	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Ifosfamide—testicular cancer	0.00399	0.00491	CcSEcCtD
Hydroflumethiazide—Headache—Vinblastine—testicular cancer	0.00399	0.00491	CcSEcCtD
Hydroflumethiazide—Leukopenia—Etoposide—testicular cancer	0.00398	0.0049	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—testicular cancer	0.00397	0.00489	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Bleomycin—testicular cancer	0.00396	0.00487	CcSEcCtD
Hydroflumethiazide—Constipation—Ifosfamide—testicular cancer	0.00393	0.00483	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Cisplatin—testicular cancer	0.00388	0.00477	CcSEcCtD
Hydroflumethiazide—ATP1A1—lymph node—testicular cancer	0.00387	0.0206	CbGeAlD
Hydroflumethiazide—Asthenia—Bleomycin—testicular cancer	0.00386	0.00475	CcSEcCtD
Hydroflumethiazide—Nausea—Vinblastine—testicular cancer	0.00378	0.00465	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—testicular cancer	0.00378	0.00465	CcSEcCtD
Hydroflumethiazide—Anorexia—Cisplatin—testicular cancer	0.00378	0.00465	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Methotrexate—testicular cancer	0.00375	0.00461	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Dactinomycin—testicular cancer	0.00369	0.00454	CcSEcCtD
Hydroflumethiazide—Urticaria—Ifosfamide—testicular cancer	0.00365	0.00449	CcSEcCtD
Hydroflumethiazide—Asthenia—Dactinomycin—testicular cancer	0.0036	0.00443	CcSEcCtD
Hydroflumethiazide—CA4—lymph node—testicular cancer	0.00357	0.0191	CbGeAlD
Hydroflumethiazide—Thrombocytopenia—Etoposide—testicular cancer	0.00355	0.00437	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—testicular cancer	0.00351	0.00431	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—testicular cancer	0.0035	0.0043	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Methotrexate—testicular cancer	0.00349	0.00429	CcSEcCtD
Hydroflumethiazide—Anorexia—Etoposide—testicular cancer	0.00346	0.00426	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Cisplatin—testicular cancer	0.00344	0.00424	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Dactinomycin—testicular cancer	0.00343	0.00422	CcSEcCtD
Hydroflumethiazide—Vomiting—Bleomycin—testicular cancer	0.00342	0.00421	CcSEcCtD
Hydroflumethiazide—Rash—Bleomycin—testicular cancer	0.00339	0.00417	CcSEcCtD
Hydroflumethiazide—Dermatitis—Bleomycin—testicular cancer	0.00339	0.00417	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Ifosfamide—testicular cancer	0.00338	0.00416	CcSEcCtD
Hydroflumethiazide—Asthenia—Ifosfamide—testicular cancer	0.0033	0.00406	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—testicular cancer	0.00326	0.00402	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—testicular cancer	0.00324	0.00399	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—testicular cancer	0.00323	0.00397	CcSEcCtD
Hydroflumethiazide—Nausea—Bleomycin—testicular cancer	0.00319	0.00393	CcSEcCtD
Hydroflumethiazide—Vomiting—Dactinomycin—testicular cancer	0.00319	0.00392	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Methotrexate—testicular cancer	0.00318	0.00391	CcSEcCtD
Hydroflumethiazide—Rash—Dactinomycin—testicular cancer	0.00316	0.00389	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Etoposide—testicular cancer	0.00315	0.00388	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Ifosfamide—testicular cancer	0.00314	0.00387	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—testicular cancer	0.00311	0.00382	CcSEcCtD
Hydroflumethiazide—Constipation—Etoposide—testicular cancer	0.0031	0.00382	CcSEcCtD
Hydroflumethiazide—Dizziness—Ifosfamide—testicular cancer	0.00304	0.00374	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00302	0.00372	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—testicular cancer	0.00299	0.00367	CcSEcCtD
Hydroflumethiazide—Nausea—Dactinomycin—testicular cancer	0.00298	0.00366	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—testicular cancer	0.00298	0.00366	CcSEcCtD
Hydroflumethiazide—CA2—lymph node—testicular cancer	0.00296	0.0158	CbGeAlD
Hydroflumethiazide—Vomiting—Ifosfamide—testicular cancer	0.00292	0.00359	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Cisplatin—testicular cancer	0.00292	0.00359	CcSEcCtD
Hydroflumethiazide—Rash—Ifosfamide—testicular cancer	0.0029	0.00356	CcSEcCtD
Hydroflumethiazide—Dermatitis—Ifosfamide—testicular cancer	0.00289	0.00356	CcSEcCtD
Hydroflumethiazide—Urticaria—Etoposide—testicular cancer	0.00288	0.00355	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—testicular cancer	0.00288	0.00354	CcSEcCtD
Hydroflumethiazide—Asthenia—Cisplatin—testicular cancer	0.00284	0.0035	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—testicular cancer	0.00275	0.00339	CcSEcCtD
Hydroflumethiazide—Nausea—Ifosfamide—testicular cancer	0.00273	0.00336	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Cisplatin—testicular cancer	0.00271	0.00333	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Etoposide—testicular cancer	0.00267	0.00329	CcSEcCtD
Hydroflumethiazide—Asthenia—Etoposide—testicular cancer	0.0026	0.0032	CcSEcCtD
Hydroflumethiazide—Vomiting—Cisplatin—testicular cancer	0.00252	0.0031	CcSEcCtD
Hydroflumethiazide—Rash—Cisplatin—testicular cancer	0.0025	0.00307	CcSEcCtD
Hydroflumethiazide—Dermatitis—Cisplatin—testicular cancer	0.00249	0.00307	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Etoposide—testicular cancer	0.00248	0.00305	CcSEcCtD
Hydroflumethiazide—Dizziness—Etoposide—testicular cancer	0.0024	0.00295	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—testicular cancer	0.0024	0.00295	CcSEcCtD
Hydroflumethiazide—Vertigo—Methotrexate—testicular cancer	0.00239	0.00294	CcSEcCtD
Hydroflumethiazide—Leukopenia—Methotrexate—testicular cancer	0.00238	0.00293	CcSEcCtD
Hydroflumethiazide—Nausea—Cisplatin—testicular cancer	0.00235	0.00289	CcSEcCtD
Hydroflumethiazide—Vomiting—Etoposide—testicular cancer	0.00231	0.00284	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—testicular cancer	0.00229	0.00282	CcSEcCtD
Hydroflumethiazide—Rash—Etoposide—testicular cancer	0.00229	0.00282	CcSEcCtD
Hydroflumethiazide—Dermatitis—Etoposide—testicular cancer	0.00229	0.00281	CcSEcCtD
Hydroflumethiazide—Headache—Etoposide—testicular cancer	0.00227	0.0028	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—testicular cancer	0.00224	0.00276	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—testicular cancer	0.00223	0.00274	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—testicular cancer	0.00222	0.00273	CcSEcCtD
Hydroflumethiazide—Nausea—Etoposide—testicular cancer	0.00216	0.00265	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Methotrexate—testicular cancer	0.00213	0.00262	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—testicular cancer	0.00212	0.00261	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—testicular cancer	0.00207	0.00255	CcSEcCtD
Hydroflumethiazide—Anorexia—Methotrexate—testicular cancer	0.00207	0.00255	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—testicular cancer	0.00206	0.00254	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—testicular cancer	0.00199	0.00245	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—testicular cancer	0.00194	0.00239	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Methotrexate—testicular cancer	0.00189	0.00232	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—testicular cancer	0.00184	0.00227	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—testicular cancer	0.00179	0.00221	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—testicular cancer	0.00177	0.00218	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—testicular cancer	0.00174	0.00214	CcSEcCtD
Hydroflumethiazide—Urticaria—Methotrexate—testicular cancer	0.00173	0.00212	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—testicular cancer	0.00164	0.00201	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—testicular cancer	0.00162	0.00199	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—testicular cancer	0.00161	0.00198	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Methotrexate—testicular cancer	0.0016	0.00197	CcSEcCtD
Hydroflumethiazide—Asthenia—Methotrexate—testicular cancer	0.00156	0.00192	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—testicular cancer	0.0015	0.00184	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—testicular cancer	0.0015	0.00184	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Methotrexate—testicular cancer	0.00149	0.00183	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—testicular cancer	0.00146	0.0018	CcSEcCtD
Hydroflumethiazide—Dizziness—Methotrexate—testicular cancer	0.00144	0.00177	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—testicular cancer	0.00139	0.00171	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—testicular cancer	0.00139	0.00171	CcSEcCtD
Hydroflumethiazide—Vomiting—Methotrexate—testicular cancer	0.00138	0.0017	CcSEcCtD
Hydroflumethiazide—Rash—Methotrexate—testicular cancer	0.00137	0.00169	CcSEcCtD
Hydroflumethiazide—Dermatitis—Methotrexate—testicular cancer	0.00137	0.00168	CcSEcCtD
Hydroflumethiazide—Headache—Methotrexate—testicular cancer	0.00136	0.00168	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—testicular cancer	0.00135	0.00166	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—testicular cancer	0.00135	0.00165	CcSEcCtD
Hydroflumethiazide—Vomiting—Epirubicin—testicular cancer	0.00129	0.00159	CcSEcCtD
Hydroflumethiazide—Nausea—Methotrexate—testicular cancer	0.00129	0.00159	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—testicular cancer	0.00129	0.00158	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—testicular cancer	0.00128	0.00158	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—testicular cancer	0.00128	0.00158	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—testicular cancer	0.00127	0.00157	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—testicular cancer	0.00124	0.00153	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—testicular cancer	0.00121	0.00149	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—testicular cancer	0.0012	0.00147	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—testicular cancer	0.00119	0.00146	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—testicular cancer	0.00119	0.00146	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—testicular cancer	0.00118	0.00145	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—testicular cancer	0.00112	0.00138	CcSEcCtD
